| protein kinase C, alpha |
RABEPRAZOLE |
Phorbol Ester |
10% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D3 |
HALOPERIDOL |
Dopamine D3 |
100% |
.02uM |
.006842uM |
View
|
| estrogen receptor 1 |
ESTRIOL |
Estrogen ERalpha |
100% |
.001691uM |
.000483uM |
View
|
| estrogen receptor 1 |
ESTRIOL |
Estrogen ERalpha |
100% |
.001691uM |
.000483uM |
View
|
| adrenergic receptor, beta 2 |
LABETALOL |
Adrenergic beta2 |
100% |
.016uM |
.011uM |
View
|
| androgen receptor |
MEGESTROL ACETATE |
Testosterone |
100% |
.03uM |
.02uM |
View
|
| progesterone receptor |
MEGESTROL ACETATE |
Progesterone |
100% |
.011uM |
.001439uM |
View
|
| progesterone receptor |
MEGESTROL ACETATE |
Progesterone |
100% |
.011uM |
.001439uM |
View
|
| prostaglandin-endoperoxide synthase 1 |
SULINDAC SULFIDE |
Cyclooxygenase COX-1 |
100% |
.688uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
SULINDAC SULFIDE |
Cyclooxygenase COX-1 |
100% |
.688uM |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
FLURANDRENOLIDE |
Glucocorticoid |
100% |
.004447uM |
.002021uM |
View
|
| prostaglandin-endoperoxide synthase 2 |
MECLOFENAMIC ACID |
Cyclooxygenase COX-2 |
100% |
.011uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
MECLOFENAMIC ACID |
Cyclooxygenase COX-2 |
100% |
.011uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
SULINDAC SULFIDE |
Aldose Reductase |
100% |
.084uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
SULINDAC SULFIDE |
Aldose Reductase |
100% |
.084uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
SULINDAC SULFIDE |
Aldose Reductase |
100% |
.084uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
SULINDAC SULFIDE |
Aldose Reductase |
100% |
.084uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
MEFENAMIC ACID |
Cyclooxygenase COX-2 |
100% |
.602uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
MEFENAMIC ACID |
Cyclooxygenase COX-2 |
100% |
.602uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
FLURBIPROFEN |
Cyclooxygenase COX-2 |
100% |
.359uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FLURBIPROFEN |
Cyclooxygenase COX-2 |
100% |
.359uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
THIORIDAZINE |
Adrenergic alpha2B |
100% |
.38uM |
.174uM |
View
|
| prostaglandin-endoperoxide synthase 2 |
DICLOFENAC |
Cyclooxygenase COX-2 |
100% |
.037uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
DICLOFENAC |
Cyclooxygenase COX-2 |
100% |
.037uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
DICLOFENAC |
Cyclooxygenase COX-1 |
100% |
.013uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DICLOFENAC |
Cyclooxygenase COX-1 |
100% |
.013uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
DOXEPIN |
Serotonin 5-HT2A |
100% |
.038uM |
.011uM |
View
|
| adrenergic receptor, alpha 1a |
DOXEPIN |
Adrenergic alpha1A |
100% |
.107uM |
.043uM |
View
|
| adrenergic receptor, alpha 2b |
DOXEPIN |
Adrenergic alpha2B |
100% |
.071uM |
.032uM |
View
|
| adrenergic receptor, alpha 1b |
DOXEPIN |
Adrenergic alpha1B |
100% |
.06uM |
.033uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
FLUOXETINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.827uM |
.736uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| protein kinase C, iota |
RABEPRAZOLE |
Phorbol Ester |
10% |
NoneNone |
NoneNone |
View
|
| arachidonate 15-lipoxygenase, second type |
HYDRALAZINE |
Lipoxygenase 15-LO |
100% |
3.649uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
HYDRALAZINE |
Lipoxygenase 15-LO |
100% |
3.649uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
HYDRALAZINE |
Lipoxygenase 15-LO |
100% |
3.649uM |
NoneNone |
View
|
| opioid receptor, sigma 1 |
EPERISONE |
Sigma1 |
100% |
.004055uM |
.001704uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel associated protein 1 |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel associated protein 2 |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type III, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type III, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type I, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type II, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| adrenergic receptor, alpha 2b |
BROMOCRIPTINE |
Adrenergic alpha2B |
100% |
.035uM |
.016uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
BROMOCRIPTINE |
Serotonin 5-HT2C |
100% |
.532uM |
.278uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
BROMOCRIPTINE |
Serotonin 5-HT2A |
100% |
.036uM |
.01uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
MOSAPRIDE |
Serotonin 5-HT4 |
100% |
.8818uM |
.147uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
MOSAPRIDE |
Serotonin 5-HT4 |
100% |
.8818uM |
.147uM |
View
|
| dopamine receptor D3 |
BROMOCRIPTINE |
Dopamine D3 |
100% |
.000596uM |
.000202uM |
View
|
| 5-hydroxytryptamine receptor 6 |
BROMOCRIPTINE |
Serotonin 5-HT6 |
100% |
.022uM |
.01uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
VERAPAMIL |
Calcium Channel Type L, Phenylalkylamine |
100% |
.047uM |
.045uM |
View
|
| arachidonate 15-lipoxygenase, second type |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Lipoxygenase 15-LO |
100% |
2.883uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Lipoxygenase 15-LO |
100% |
2.883uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Lipoxygenase 15-LO |
100% |
2.883uM |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
LEFLUNOMIDE |
CYP450-1A2 Inhibition |
100% |
.5uM |
NoneNone |
View
|
| protein tyrosine phosphatase, receptor type, C |
ZIRCONIUM(IV) CHLORIDE |
Protein Tyrosine Phosphatase, CD45 |
100% |
.357uM |
NoneNone |
View
|
| protein tyrosine phosphatase, receptor type, C |
ZIRCONIUM(IV) CHLORIDE |
Protein Tyrosine Phosphatase, CD45 |
100% |
.357uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
MITOXANTRONE |
Muscarinic M1 |
100% |
.7487uM |
.1803uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type II, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type I, beta |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
GENTIAN VIOLET |
Sodium Channel, Site 2 |
100% |
.46uM |
.419uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
TRAZODONE |
Serotonin 5-HT2A |
100% |
.02uM |
.005602uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
TRAZODONE |
Serotonin 5-HT2C |
100% |
.091uM |
.047uM |
View
|
| dopamine receptor D3 |
GENTIAN VIOLET |
Dopamine D3 |
100% |
.831uM |
.282uM |
View
|
| tachykinin receptor 2 |
GENTIAN VIOLET |
Tachykinin NK2 |
100% |
1.679uM |
.56uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
HALOPERIDOL |
Adrenergic alpha1D |
100% |
.084uM |
.041uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel associated protein 1 |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel associated protein 2 |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type III, beta |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type III, beta |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type I, beta |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
HALOPERIDOL |
Sodium Channel, Site 2 |
100% |
.158uM |
.144uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MEPAZINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
1.546uM |
1.503uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
2-ACETYLAMINOFLUORENE |
CYP450-1A2 Inhibition |
100% |
.016uM |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
METHYSERGIDE |
Serotonin 5-HT6 |
100% |
.162uM |
.075uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
METHYLPREDNISOLONE |
Glucocorticoid |
100% |
.011uM |
.005033uM |
View
|
| mu-opioid receptor MOR |
LOPERAMIDE |
Opiate mu |
100% |
.001445uM |
.000586uM |
View
|
| adrenergic receptor, alpha 2b |
LYSERGOL |
Adrenergic alpha2B |
100% |
.027uM |
.012uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
LYSERGOL |
Serotonin 5-HT2A |
100% |
.008694uM |
.002484uM |
View
|
| cholinergic receptor, muscarinic 5 |
MEPAZINE |
Muscarinic M5 |
100% |
.04uM |
.028uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
MEPAZINE |
Serotonin 5-HT2A |
100% |
.385uM |
.11uM |
View
|
| cholinergic receptor, muscarinic 4 |
MEPAZINE |
Muscarinic M4 |
100% |
.137uM |
.019uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
METHYSERGIDE |
Serotonin 5-HT2B |
100% |
.000563uM |
.000358uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
METHYSERGIDE |
Serotonin 5-HT1A |
100% |
.054uM |
.031uM |
View
|
| dopamine receptor D3 |
LYSERGOL |
Dopamine D3 |
100% |
.027uM |
.009336uM |
View
|
| 5-hydroxytryptamine receptor 6 |
LYSERGOL |
Serotonin 5-HT6 |
100% |
.001699uM |
.000789uM |
View
|
| adrenergic receptor, beta 2 |
LEVOBUNOLOL |
Adrenergic beta2 |
100% |
.000793uM |
.000546uM |
View
|
| adrenergic receptor, alpha 2b |
MIANSERIN |
Adrenergic alpha2B |
100% |
.052uM |
.024uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
MIANSERIN |
Serotonin 5-HT2C |
100% |
.001158uM |
.000606uM |
View
|
| 5-hydroxytryptamine receptor 6 |
MIANSERIN |
Serotonin 5-HT6 |
100% |
.085uM |
.04uM |
View
|
| prostaglandin-endoperoxide synthase 1 |
FENOPROFEN |
Cyclooxygenase COX-1 |
100% |
.145uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
FENOPROFEN |
Cyclooxygenase COX-1 |
100% |
.145uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FELODIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000082uM |
.000053uM |
View
|
| sodium channel, voltage-gated, type I, beta |
CARVEDILOL |
Sodium Channel, Site 2 |
100% |
.455uM |
.415uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
CARVEDILOL |
Sodium Channel, Site 2 |
100% |
.455uM |
.415uM |
View
|
| cholinergic receptor, muscarinic 5 |
CLOMIPRAMINE |
Muscarinic M5 |
100% |
.053uM |
.038uM |
View
|
| progesterone receptor |
CHLORMADINONE ACETATE |
Progesterone |
100% |
.005265uM |
.000687uM |
View
|
| progesterone receptor |
CHLORMADINONE ACETATE |
Progesterone |
100% |
.005265uM |
.000687uM |
View
|
| cholinergic receptor, muscarinic 5 |
CLEMASTINE |
Muscarinic M5 |
100% |
.008373uM |
.006016uM |
View
|
| adrenergic receptor, alpha 2b |
CARVEDILOL |
Adrenergic alpha2B |
100% |
.094uM |
.043uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
FLUOCINOLONE ACETONIDE |
Glucocorticoid |
100% |
.003131uM |
.001423uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
CLOZAPINE |
Adrenergic alpha1D |
100% |
.035uM |
.017uM |
View
|
| cholinergic receptor, muscarinic 5 |
CLOZAPINE |
Muscarinic M5 |
100% |
.013uM |
.009532uM |
View
|
| adrenergic receptor, alpha 1a |
CLOZAPINE |
Adrenergic alpha1A |
100% |
.038uM |
.015uM |
View
|
| adrenergic receptor, alpha 2b |
CLOMIPRAMINE |
Adrenergic alpha2B |
100% |
.101uM |
.046uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CLOMIPRAMINE |
Serotonin Transporter |
100% |
.000088uM |
.000047uM |
View
|
| histamine receptor H 1 |
CLOMIPRAMINE |
Histamine H1, Central |
100% |
.085uM |
.009827uM |
View
|
| adrenergic receptor, alpha 2b |
CLOZAPINE |
Adrenergic alpha2B |
100% |
.023uM |
.011uM |
View
|
| cholinergic receptor, muscarinic 1 |
ATROPINE |
Muscarinic M1 |
100% |
.001521uM |
.000366uM |
View
|
| cholinergic receptor, muscarinic 5 |
ATROPINE |
Muscarinic M5 |
100% |
.000922uM |
.000662uM |
View
|
| dopamine receptor D3 |
CLOMIPRAMINE |
Dopamine D3 |
100% |
.139uM |
.047uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
CLOMIPRAMINE |
Serotonin 5-HT2A |
100% |
.067uM |
.019uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
CLOMIPRAMINE |
Sodium Channel, Site 2 |
100% |
.742uM |
.677uM |
View
|
| sodium channel associated protein 1 |
CLOMIPRAMINE |
Sodium Channel, Site 2 |
100% |
.742uM |
.677uM |
View
|
| sodium channel associated protein 2 |
CLOMIPRAMINE |
Sodium Channel, Site 2 |
100% |
.742uM |
.677uM |
View
|
| sodium channel, voltage-gated, type III, beta |
CLOMIPRAMINE |
Sodium Channel, Site 2 |
100% |
.742uM |
.677uM |
View
|
